Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Alexion, Analyst, Bank, bear, Beijing, Bogang, card, category, cava, CEI, CFA, charterholder, Chicago, Chinese, Chu, CMC, collateral, conference, deferral, deterring, embedded, feature, fifteen, FIRRMA, Fodor, freestanding, gene, genome, hematopoietic, Heping, histocompatibility, Hong, Huanggang, Hubei, IL, immunobiology, immunology, indirect, intelligence, Jinhui, journal, Liu, liver, Mandatorily, MDET, MHC, minimal, Modernization, Molecular, NOL, Noncontrolling, Nonpublic, Ohio, Orgagen, ourin, outsourced, pancreatic, Peking, PhD, potency, prepaid, pronouncement, prospectively, reconstructed, reconstruction, Redeemable, redeemed, regrowth, reinstated, reinstating, rejoined, Renminbi, repayment, revealed, round, RSM, scientist, seasoned, Shmerling, strong, tariff, thePublic, Transgenic, vast, vena, ViaCell, wealth, William, worst, Xiaoyu, Yale, Yu, Zhou, zone
Removed:
approximate, ASC, assured, buyer, claiming, Codification, collectability, committed, determinable, EU, faced, footnote, GMP, implying, import, installation, installed, leased, misappropriation, mixed, NFS, overhead, penalty, persuasive, PLC, researcher, shipment, shipped, translated, UCL, UCLB, Unaudited, validity, violate, warranty
Filing tables
Filing exhibits
Related press release
Associated HRGN transcripts
HRGN similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation byreference in the Registration Statements on Form S-1 (No. 333-215410), Form S-3 (No. 333-212992), and Forms S-8 (No. 333-192026, 333-192027, 333-203105, 333-212993, 333-219988, 333-225336) of Biostage, Inc. and subsidiaries of our report dated March 22, 2019, relating to the consolidated financial statements of Biostage, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of Biostage, Inc. for the year ended December 31, 2018.
/s/ RSM US LLP
Boston, Massachusetts
March 29, 2019